Jiren Yu

1.7k total citations
56 papers, 960 citations indexed

About

Jiren Yu is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Surgery. According to data from OpenAlex, Jiren Yu has authored 56 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 22 papers in Gastroenterology and 20 papers in Surgery. Recurrent topics in Jiren Yu's work include Gastric Cancer Management and Outcomes (26 papers), Gastrointestinal Tumor Research and Treatment (22 papers) and Metastasis and carcinoma case studies (11 papers). Jiren Yu is often cited by papers focused on Gastric Cancer Management and Outcomes (26 papers), Gastrointestinal Tumor Research and Treatment (22 papers) and Metastasis and carcinoma case studies (11 papers). Jiren Yu collaborates with scholars based in China, Japan and United States. Jiren Yu's co-authors include Xiaosun Liu, Hailong Jin, Geer Zhang, Xianke Lin, Xiaomei Huang, Jianyi Sun, Hang Yu, Qing Zhang, Weili Yang and Hang Yu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jiren Yu

53 papers receiving 942 citations

Peers

Countries citing papers authored by Jiren Yu

Since Specialization

Citations

This map shows the geographic impact of Jiren Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiren Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiren Yu more than expected).

Fields of papers citing papers by Jiren Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiren Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiren Yu. The network helps show where Jiren Yu may publish in the future.

Co-authorship network of co-authors of Jiren Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiren Yu. A scholar is included among the top collaborators of Jiren Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiren Yu. Jiren Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Gastric gastrointestinal stromal tumors: therapeutic strategies and long-term prognosis	Scandinavian Journal of Gastroenterology	Zhou Chen, Weili Yang et al.	0
2	Co-targeting of ACK1 and KIT triggers additive anti-proliferative and -migration effects in imatinib-resistant gastrointestinal stromal tumors	Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease	Liangliang Xu, Weili Yang et al.	7
3	LBA78 Overall survival of perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy: An updated analysis of RESOLVE trial	Annals of Oncology	Xianghua Zhang, Liang Han et al.	6
4	CT features combined with RECIST 1.1 criteria improve progression assessments of sunitinib-treated gastrointestinal stromal tumors	European Radiology	Jiazheng Li, Hui Zhu et al.	1
5	The prognostic role of gastrointestinal bleeding in patients with a primary gastrointestinal stromal tumor: a long-term follow-up study	Journal of Gastrointestinal Oncology	Xiaoxiao Shi, Zhou Chen et al.	1
6	Large-Scale, Multicenter, Prospective Registry Study of Ripretinib in Advanced GIST: A Real-World Study from China	Advances in Therapy	Peng Zhang, Haibo Qiu et al.	4
7	Elevated preoperative controlling nutritional status (CONUT) scores as a predictor of postoperative recurrence in gastrointestinal stromal tumors	Journal of Surgical Oncology	Weili Yang, Jiren Yu et al.	1
8	Reassessment of the recurrence risk of primary gastrointestinal stromal tumour after complete resection	Scandinavian Journal of Gastroenterology	Weili Yang, Zhou Chen et al.	2
9	Clinicopathologic Characteristics and Prognosis of PDGFRA-Mutant Gastrointestinal Stromal Tumors: A Large-Scale, Multi-Institutional, Observational Study in China	Advances in Therapy	Peng Zhang, Ming Wang et al.	0
10	The Prognostic Value of Lymph Node Ratio after Neoadjuvant Chemotherapy in Patients with Locally Advanced Gastric Adenocarcinoma	Journal of the Korean Gastric Cancer Association	Hailong Jin, Yuan Gao et al.	4
11	ypT0 gastric carcinoma after preoperative chemotherapy: a unique status according to AJCC 8th edition cancer staging system	Translational Cancer Research	Hailong Jin, Qing Zhang et al.	3
12	Regulatory T Cells Promote Overexpression of Lgr5 on Gastric Cancer Cells via TGF-beta1 and Confer Poor Prognosis in Gastric Cancer	Frontiers in Immunology	Xiaosun Liu, Xianke Lin et al.	41
13	Neoadjuvant chemotherapy in controlling lymph node metastasis for locally advanced gastric cancer in a Chinese population	Journal of Chemotherapy	Shuai Dong, Jiren Yu et al.	13
14	Intratumor IL-17-Positive Mast Cells Are the Major Source of the IL-17 That Is Predictive of Survival in Gastric Cancer Patients	PLoS ONE	Xiaosun Liu, Hailong Jin et al.	49
15	Preoperative imatinib facilitates complete resection of locally advanced primary GIST by a less invasive procedure	Medical Oncology	Weili Yang, Jiren Yu et al.	6
16	Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer	PLoS ONE	Zhongwei Zhang, Yifeng Sun et al.	18
17	Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy	World Journal of Surgical Oncology	Hailong Jin, Geer Zhang et al.	65
18	Decreased Levels of Active SMAD2 Correlate with Poor Prognosis in Gastric Cancer	PLoS ONE	Yijun Wu, Qi Li et al.	25
19	Duodenal gastrointestinal stromal tumor: Clinical, pathologic, immunohistochemical characteristics, and surgical prognosis	Journal of Surgical Oncology	Weili Yang, Jiren Yu et al.	41
20	Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long‐term prognosis	Journal of Surgical Oncology	Akio Yamaguchi, Takanori Goi et al.	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact